ACETOHEXAMIDE

Acetohexamide is a sulfonylurea that stimulates pancreatic insulin release, lowering blood glucose in type 2 diabetes. Benefits include reliable glycemic control. Risks include hypoglycemia, weight gain, GI disturbances, and hypersensitivity reactions. Caution is needed in elderly or renally impaired patients.

SKU: 0be61f6d5443 Category: Tag:

Product Description


Mechanism of action

Acetohexamide is a first‑generation sulfonylurea oral hypoglycaemic agent. It stimulates insulin secretion from functioning pancreatic beta cells by binding to the sulfonylurea receptor (SUR1) component of ATP‑sensitive potassium channels, causing channel closure, membrane depolarisation, calcium influx and insulin release.

Benefits and advantages

Acetohexamide has been used in type 2 diabetes mellitus to improve fasting and postprandial blood glucose control when diet and exercise alone are insufficient. Its long clinical history and well‑characterised pharmacology make it a reference compound in diabetology research and formulation science.

Side effects and risks

The major risk is hypoglycaemia, which can be severe and prolonged, particularly in elderly patients or those with renal or hepatic impairment. Other adverse effects include weight gain, gastrointestinal upset, hyponatraemia and, rarely, haematological reactions or hypersensitivity. Careful patient selection, education and monitoring are essential in therapeutic use. The API is potent and should be handled under appropriate industrial safety standards.

Datasheet


Molecular Formula

C15H20N2O4S

Molecular Weight

324.4 g/mol

CAS Number

968-81-0

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

less than 1 mg/mL at 64 °F (NTP, 1992)

Purity

Purity information is available upon request (COA).

Synonym

acetohexamide; 968-81-0; Dymelor; Acetohexamid; Dimelor

IUPAC/Chemical Name

1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea

InChl Key

VGZSUPCWNCWDAN-UHFFFAOYSA-N

InChl Code

InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)

References

https://pubchem.ncbi.nlm.nih.gov/compound/1989;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download